Feature from World Bio Market Insights: Cell-free biomanufacturing could reduce costs and waste, helping bio-industries scale.
Excerpts
Most biomanufacturing relies on living cells. Yet life is complex and unpredictable. Organisms are prone to waste, inefficiency and delays: all barriers to industrial scaling. This is why some biobased producers are turning to cell-free production – an emerging approach that could define the future of renewable manufacturing. [...]
eXoZymes is a company heavily involved in shaping the direction of US bio-industries. eXoZymes CCO Damien Perriman and VP of development Paul Opgenorth were elected to key Governance Committees at BioMADE, the biggest US bioindustry group.
eXoZymes is attracting attention from the federal government too. In July 2026, it was selected to participate in the inaugural U.S. Department of Energy (DOE) Genesis Mission – a nine-month project where eXoZymes will collaborate with Lawrence Berkeley National Laboratory (LBNL).
Full feature available here.